R Donald Harvey

R Donald Harvey

Emory University - Atlanta / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 1352384
person_outline R Donald Harvey's MOST POPULAR ARTICLES
1-) Preventing and managing toxicities of high-dose methotrexateSC Howard, J McCormick, CH Pui, RK Buddington, RD HarveyThe oncologist 21 (12), 1471-1482, 20165642016
2-) Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studiesD Siegel, T Martin, A Nooka, RD Harvey, R Vij, R Niesvizky, AZ Badros, ...Haematologica 98 (11), 1753, 20133372013
3-) Withaferin A inhibits breast cancer invasion and metastasis at sub‐cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylationJT Thaiparambil, L Bender, T Ganesh, E Kline, P Patel, Y Liu, ...International journal of cancer 129 (11), 2744-2755, 20112962011
4-) Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myelomaWG Tong, R Chen, W Plunkett, D Siegel, R Sinha, RD Harvey, AZ Badros, ...Journal of clinical oncology 28 (18), 3015-3022, 20102552010
5-) Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patientsPG Richardson, R Baz, M Wang, AJ Jakubowiak, JP Laubach, RD Harvey, ...Blood, The Journal of the American Society of Hematology 124 (7), 1038-1046, 20142342014